5th Circ. Tells Watson It Can't Review Fentanyl Jurisdiction

Law360, New York (June 11, 2013, 6:53 PM EDT) -- The Fifth Circuit on Monday upheld an order shipping a fentanyl wrongful death suit against Watson Pharmaceutical Inc. back to state court, joining five sister circuits in holding that remand orders for lack of subject matter jurisdiction are off-limits for appellate court review.

The unanimous appeals panel found that a Louisiana federal judge’s order remanding the malpractice and product liability suit back to state court fell outside the scope of appellate review, preventing it from ruling on Watson's challenge to the order. Looking to keep the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.